4//SEC Filing
ABEL DOUGLAS 4
Accession 0001140361-10-011213
CIK 0001001316other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:06 PM ET
Size
9.4 KB
Accession
0001140361-10-011213
Insider Transaction Report
Form 4
ABEL DOUGLAS
Director
Transactions
- Award
Stock Options
2010-03-03+50,000→ 50,000 totalExercise: $0.07Exp: 2020-03-02→ Common Stock (50,000 underlying)
Holdings
- 1,300,000
Stock Options
Exercise: $0.17Exp: 2018-03-25→ Common Stock (1,300,000 underlying) - 24,000
Warrant
Exercise: $0.20Exp: 2013-09-10→ Common Stock (24,000 underlying) - 55,000
Common Stock
Footnotes (4)
- [F1]The option vested as to 433,333 shares on March 25, 2008 and as to an additional 433,334 shares on March 25, 2009. The remaining 433,334 shares are scheduled to vest on March 25, 2010.
- [F2]The warrants are exercisable immediately.
- [F3]On March 3, 2010, the reporting person was granted an option to purchase 50,000 shares of common stock of Manhattan Pharmaceuticals, Inc. under the 2003 Stock Option Plan.
- [F4]The option is scheduled to vest (i) as to 16,667 shares on each of March 3, 2011 and March 3, 2012, and (ii) as to the remaining 16,666 shares on March 3, 2013.
Documents
Issuer
MANHATTAN PHARMACEUTICALS INC
CIK 0001001316
Entity typeother
Related Parties
1- filerCIK 0001324106
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 6:06 PM ET
- Size
- 9.4 KB